# OnCo record paper-nct02861573-eur-urol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct02861573-eur-urol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct02861573-eur-urol-2022" ;
  schema:name "Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study"@en ;
  schema:description "Published report from the KEYNOTE-365 trial registered as NCT02861573, in European Urology (2022), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct02861573-eur-urol-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.eururo.2022.02.023>, <https://pubmed.ncbi.nlm.nih.gov/35397952/>, <https://europepmc.org/article/MED/35397952>, <https://clinicaltrials.gov/study/NCT02861573> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.eururo.2022.02.023> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Yu EY, Kolinsky MP, Berry WR, et al." ;
  onco:trials <https://onco.cc/trials/nct02861573/> ;
  onco:journals <https://onco.cc/journals/european-urology/> .